Table of Contents Author Guidelines Submit a Manuscript
Cardiology Research and Practice
Volume 2011 (2011), Article ID 925104, 4 pages
http://dx.doi.org/10.4061/2011/925104
Case Report

Giant Cell Myocarditis with Incessant Ventricular Arrhythmias Treated Successfully with Methylprednisolone and Rat Antithymocyte Globulin

Department of Cardiology, Western Sussex Hospitals NHS Trust, Lyndhurst Road, Worthing, West Sussex BN11 2DH, UK

Received 20 December 2010; Revised 13 February 2011; Accepted 27 February 2011

Academic Editor: Firat Duru

Copyright © 2011 Mudassar Baig and Rob Hatrick. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. T. Cooper, “Giant cell myocarditis: diagnosis and treatment,” Herz, vol. 25, no. 3, pp. 291–298, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. R. C. Shields, H. D. Tazelaar, G. J. Berry, and L. T. Cooper, “The role of right ventricular endomyocardial biopsy for idiopathic giant cell myocarditis,” Journal of Cardiac Failure, vol. 8, no. 2, pp. 74–78, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. L. T. Cooper Jr., G. J. Berry, and R. Shabetai, “Idiopathic giant cell myocarditis—natural history and treatment. Multicenter giant cell myocarditis study group investigators,” England Journal of Medicine, vol. 336, pp. 1860–1866, 1997. View at Google Scholar
  4. M. Weidenbach, T. Springer, I. Daehnert, K. Klingel, S. Doll, and J. Janoušek, “Giant cell myocarditis mimicking idiopathic fascicular ventricular tachycardia,” Journal of Heart and Lung Transplantation, vol. 27, no. 2, pp. 238–241, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. H. J. Ankersmit, R. Ullrich, B. Moser et al., “Recovery from giant cell myocarditis with ECMO support and utilisation of polyclonal antithymocyte globulin: a case report,” Thoracic and Cardiovascular Surgeon, vol. 54, no. 4, pp. 278–280, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. R. L. Scott, N. B. Ratliff, R. C. Starling, and J. B. Young, “Recurrence of giant cell myocarditis in cardiac allograft,” Journal of Heart and Lung Transplantation, vol. 20, no. 3, pp. 375–380, 2001. View at Publisher · View at Google Scholar
  7. R. A. Davies, J. P. Veinot, S. Smith, C. Struthers, P. Hendry, and R. Masters, “Giant cell myocarditis: clinical presentation, bridge to transplantation with mechanical circulatory support, and long-term outcome,” Journal of Heart and Lung Transplantation, vol. 21, no. 6, pp. 674–679, 2002. View at Publisher · View at Google Scholar
  8. K. Shioji, C. Kishimoto, Y. Nakayama, and S. Sasayama, “Strain difference in rats with experimental giant cell myocarditis,” Japanese Circulation Journal, vol. 64, no. 4, pp. 283–286, 2000. View at Publisher · View at Google Scholar
  9. L. T. Cooper Jr., J. M. Hare, H. D. Tazelaar et al., “Usefulness of immunosuppression for giant cell myocarditis,” American Journal of Cardiology, vol. 102, no. 11, pp. 1535–1539, 2008. View at Publisher · View at Google Scholar · View at PubMed